Skip to main content

What’s New

Latest News

a woman holds her head in her hands
Research Summary
09/01/2026
Maria Mantas
Negative expectations about the future were associated with differences in brain structure and a longer course of depressive illness among patients with MDD.
Negative expectations about the future were associated with differences in brain structure and a longer course of depressive illness among patients with MDD.
Negative expectations about the...
09/01/2026
Psych Congress Network
Psych Congress Network
News
09/01/2026
Stephanie Holland
Five-year results from the phase 3 KEYNOTE-671 trial showed that perioperative pembrolizumab plus neoadjuvant chemotherapy provided durable event-free and overall survival benefits compared with neoadjuvant chemotherapy and surgery alone in...
Five-year results from the phase 3 KEYNOTE-671 trial showed that perioperative pembrolizumab plus neoadjuvant chemotherapy provided durable event-free and overall survival benefits compared with neoadjuvant chemotherapy and surgery alone in...
Five-year results from the phase...
09/01/2026
Oncology
Oncology
News
08/31/2026
Rebecca Amrick
Researchers found that rituximab biosimilars were associated with similar health outcomes and lower care costs than originator rituximab when used to treat patients with non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL).
Researchers found that rituximab biosimilars were associated with similar health outcomes and lower care costs than originator rituximab when used to treat patients with non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL).
Researchers found that rituximab...
08/31/2026
Journal of Clinical Pathways
Journal of Clinical Pathways
News
08/31/2026
Rebecca Amrick
The Veterans Health Administration’s TeleWound Practice Program expanded access and continuity of chronic wound care, while participants identified technical issues, education, and provider workload as key considerations for broader...
The Veterans Health Administration’s TeleWound Practice Program expanded access and continuity of chronic wound care, while participants identified technical issues, education, and provider workload as key considerations for broader...
The Veterans Health...
08/31/2026
Veterans Health Today
Veterans Health Today
Behind the Bill
08/28/2026
Grace Taylor, MS, MA
The Centers for Medicare & Medicaid Services (CMS) is rolling out Rural Health Transformation Program funding across states, supporting projects aimed at expanding access, modernizing infrastructure, and strengthening rural health care...
The Centers for Medicare & Medicaid Services (CMS) is rolling out Rural Health Transformation Program funding across states, supporting projects aimed at expanding access, modernizing infrastructure, and strengthening rural health care...
The Centers for Medicare &...
08/28/2026
First Report Managed Care
First Report Managed Care
News
08/27/2026
Rebecca Amrick
Libtayo (cemiplimab-rwlc) injection is under a voluntary Class II recall due to a lack of assurance of the product’s sterility, affecting 21 353 vials.
Libtayo (cemiplimab-rwlc) injection is under a voluntary Class II recall due to a lack of assurance of the product’s sterility, affecting 21 353 vials.
Libtayo (cemiplimab-rwlc)...
08/27/2026
Pharmacy Learning Network
Pharmacy Learning Network

Latest Research

sept 2026
Vol. 26, Issue 9, Issue September 2026
July/August 2026
Vol. 34, Issue 5, Issue September 2026
EMS World Summer 2026 Issue
Vol. 55, Issue 2, Issue September 2026

HMP Global Learning Network

Featured Interviews

Raj Chovatiya
Videos
09/01/2026
Raj Chovatiya, MD, PhD; Riya Gandhi, MA
Dr Raj Chovatiya explains how type 2 inflammation drives mast cell activation in chronic spontaneous urticaria (CSU), highlighting the roles of IL-4, IL-13, and IgE in both immune and neuroimmune pathways.
Dr Raj Chovatiya explains how type 2 inflammation drives mast cell activation in chronic spontaneous urticaria (CSU), highlighting the roles of IL-4, IL-13, and IgE in both immune and neuroimmune pathways.
Dr Raj Chovatiya explains how...
09/01/2026
The Dermatologist
Desiree Matthews, PMHNP-BC
Clinical Pearls
08/31/2026
Desiree Matthews, PHMNP-BC
Desiree Matthews, PMHNP-BC, offers a framework for choosing an initial antidepressant agent for major depressive disorder.
Desiree Matthews, PMHNP-BC, offers a framework for choosing an initial antidepressant agent for major depressive disorder.
Desiree Matthews, PMHNP-BC,...
08/31/2026
Psych Congress NP Institute
A “sensory ambulance” is now actively in use by the neo-peds transport team from Golisano Children's Hospital in Southwest Florida. Here’s a behind-the-scenes tour as to how insights from parents, children, and EMS professionals helped create and customize the ambulance.
Videos
08/25/2026
Scott DeBoer, RN, MSN, CPEN, CEN, CCRN, CFRN
A “sensory ambulance” is now actively in use by the neo-peds transport team from Golisano Children's Hospital in Southwest Florida.
A “sensory ambulance” is now actively in use by the neo-peds transport team from Golisano Children's Hospital in Southwest Florida.
A “sensory ambulance” is now...
08/25/2026
EMSWorld
Amy paller
Videos
08/01/2026
Amy S. Paller, MD, MS; Riya Gandhi, MA
Dr Amy Paller discusses how advances in understanding type 2 inflammation are transforming pediatric atopic dermatitis care.
Dr Amy Paller discusses how advances in understanding type 2 inflammation are transforming pediatric atopic dermatitis care.
Dr Amy Paller discusses how...
08/01/2026
The Dermatologist
Murugiah_title_slide
Author Interview
07/31/2026
Karthik Murugiah, MBBS, MHS
Dr Karthik Murugiah shares background and insights on his article, “Adoption of Intravascular Imaging Use Among Intermediate to High-Volume Operators in the United States From 2019 to 2023: A Medicare Data Analysis.”
Dr Karthik Murugiah shares background and insights on his article, “Adoption of Intravascular Imaging Use Among Intermediate to High-Volume Operators in the United States From 2019 to 2023: A Medicare Data Analysis.”
Dr Karthik Murugiah shares...
07/31/2026
Journal of Invasive Cardiology
Erin Crown, MHS, PA-C, CAQ-Psychiatry
Clinical Pearls
07/31/2026
Erin Crown, MHS, PA-C, CAQ
In this video, Erin Crown, MHS, PA-C, CAQ-Psychiatry, shares her approach to deciding when to augment rather than switch antidepressant therapy. 
In this video, Erin Crown, MHS, PA-C, CAQ-Psychiatry, shares her approach to deciding when to augment rather than switch antidepressant therapy. 
In this video, Erin Crown, MHS,...
07/31/2026
Psych Congress NP Institute
Thumbnail
Videos
07/30/2026
Meagan Farnie, BSN, RN; Pablo Saenz, PharmD; Dean Tuel; Jeff Yorio, MD
The panel outlines how to operationalize subcutaneous immunotherapy in clinical practice, covering efficacy and safety review, insurance and workflow considerations, and strategies for educating patients and care teams during the transition.
The panel outlines how to operationalize subcutaneous immunotherapy in clinical practice, covering efficacy and safety review, insurance and workflow considerations, and strategies for educating patients and care teams during the transition.
The panel outlines how to...
07/30/2026
Oncology
Bruce Sands
Expert Insights
07/19/2026
Bruce E. Sands, MD, MS
Dr Sands reviews the results of the DUET-CD study of combination therapy with guselkumab and golimumab in patients with Crohn's disease, which showed a significant increase in efficacy for the combination versus either drug independently.
Dr Sands reviews the results of the DUET-CD study of combination therapy with guselkumab and golimumab in patients with Crohn's disease, which showed a significant increase in efficacy for the combination versus either drug independently.
Dr Sands reviews the results of...
07/19/2026
Advances in Inflammatory Bowel Disease Network
Part 5 panel
Videos
06/24/2026
Christopher Barker, MD; Krupal Patel, MD, MSc, FRCSC, FACS; John Strasswimmer, MD, PhD, FAAD, FACMS; Deborah J.L. Wong, MD, PhD
The roundtable discussion concludes with a review of the safety profile of adjuvant cemiplimab and best practices for monitoring and managing adverse events in patients with high-risk CSCC, with an emphasis on multidisciplinary follow-up,...
The roundtable discussion concludes with a review of the safety profile of adjuvant cemiplimab and best practices for monitoring and managing adverse events in patients with high-risk CSCC, with an emphasis on multidisciplinary follow-up,...
The roundtable discussion...
06/24/2026
The Dermatologist
Oncology Learning Network Live Daily
06/19/2026
Beth Faiman, CNP, PhD; Donna Catamero, ANP-BC, OCN, CCRC
Clinicians discuss key updates in multiple myeloma and plasma cell disorders.
Clinicians discuss key updates in multiple myeloma and plasma cell disorders.
Clinicians discuss key updates...
06/19/2026
Oncology